Subscribe
Sign Up Now!
To sign up for our newsletter or print publications, please enter your contact information below and click "Subscribe".
First Name
*
Last Name
*
Email Address
*
Email Address (Verify)
*
VBCR Print Edition
We will request your mailing address on the next page.
VBCR E-Newsletters & Communications
I have reviewed and consent to the terms of
VBCR
's
Privacy Policy
, and
VBCR
has my permission to retain my information in its database, and to forward pertinent communications to me.
Home
Issues
2018
April 2018, Vol 7, No 1
2017
December 2017, Vol 6, No 5
October 2017, Vol 6, No 4
August 2017, Vol 6, No 3
June 2017, Vol 6, No 2
April 2017, Vol 6, No 1
2016
December 2016, Vol 5, No 6
October 2016, Vol 5, No 5
August 2016, Vol 5, No 4
June 2016, Vol 5, No 3
April 2016, Vol 5, No 2
February 2016, Vol 5, No 1
Issues Archive
Supplements
Categories
Web Exclusives
All Web Exclusives
FDA Approvals, News & Updates
In The News
Online First
Videos
CE
About
About VBCR
About Engage HC
Contact Us
Editorial/Publishing Policies
Editorial Board
Advertising Contacts
Advertising Policy
Author Guidelines
Thursday, 28 January 2021
Authored Items
Simvastatin plus Vitamin D May Prevent Headaches in Adults with Migraines
Chase Doyle
VBCN - November 2016 Volume 3, No 3
in
Migraine Update
The Causes and Consequences of Misdiagnosing Multiple Sclerosis
Chase Doyle
VBCN - November 2016 Volume 3, No 3
in
Multiple Sclerosis
Brain–Computer Interfaces Breaking New Ground in Patients with Neurologic Disability
Chase Doyle
VBCN - November 2016 Volume 3, No 3
in
Brain Technology
Idalopirdine Improves Cognition in Patients with Moderate Alzheimer’s Disease
Chase Doyle
VBCN - November 2016 Volume 3, No 3
in
Alzheimer’s Disease/Dementia
Pro and Con: Do Cognitive-Enhancing Activities Prevent Dementia?
Chase Doyle
VBCN - November 2016 Volume 3, No 3
in
Alzheimer’s Disease/Dementia
Alzheimer’s Prevention Clinic: A New Approach to Disease Management Shows Benefits
Chase Doyle
VBCN - November 2016 Volume 3, No 3
in
Alzheimer’s Disease/Dementia
Neuro-Oncology Update for Neurologists
Chase Doyle
Web Exclusives
in
Neurology News
Better Care Is Less Costly; Quality Improvement Through Process Management
Chase Doyle
VBCN - July 2016 Volume 3, No 2
in
Value in Neurology
Ocrelizumab Promotes No Evidence of Disease Activity in Multiple Sclerosis
Chase Doyle
VBCN - July 2016 Volume 3, No 2
in
Emerging Therapies
Emerging Disease-Modifying Therapies for Multiple Sclerosis
Chase Doyle
VBCN - July 2016 Volume 3, No 2
in
Emerging Therapies
Dichlorphenamide Improves Outcomes in Periodic Paralysis
Chase Doyle
VBCN - July 2016 Volume 3, No 2
in
Emerging Therapies
Experts Debate the Benefits of Early Aggressive Therapy in Multiple Sclerosis
Chase Doyle
VBCN - July 2016 Volume 3, No 2
in
Multiple Sclerosis
Natalizumab Shows Significant Benefit in Slowing Disability Progression in Multiple Sclerosis
Chase Doyle
VBCN - July 2016 Volume 3, No 2
in
Multiple Sclerosis
Zika Virus Linked to Guillain-Barré Syndrome
Chase Doyle
VBCN - July 2016 Volume 3, No 2
in
Neurologic Disorders Update
Individualizing Antiepileptic Drug Therapy: Consider the Side Effects
Chase Doyle
VBCN - July 2016 Volume 3, No 2
in
Epilepsy/Seizures
Poor Response to Acute Migraine Treatment May Lead to Headache Progression
Chase Doyle
VBCN - July 2016 Volume 3, No 2
in
Migraine Update
Magnetic Stimulation Decreases "Freezing" Episodes in Parkinson's Disease, Improves Patient Outcomes
Chase Doyle
VBCN - July 2016 Volume 3, No 2
in
Parkinson’s Disease
Adverse Events Associated with Tyrosine Kinase Inhibitors Carry High Economic Burden
Chase Doyle
VBCC - May 2016, Vol 7, No 4
in
Value in Oncology
Multidisciplinary Teamwork Needed for Survivorship Care
Chase Doyle
VBCC - May 2016, Vol 7, No 4
in
Survivorship
Decision Aids: Facilitating Communication with Cancer Survivors
Chase Doyle
VBCC - May 2016, Vol 7, No 4
in
Survivorship
Imatinib Can Be Safely Discontinued in Patients with Deep Molecular Response
Chase Doyle
Web Exclusives
in
Hematologic Cancers
Improving Survivorship Care: A Patient Advocate's Prescription
Chase Doyle
VBCC - April 2016, Vol 7, No 3
in
Survivorship
Cost of Care Not Linked to Improved Survival for Elderly Patients with Myelodysplastic Syndromes
Chase Doyle
VBCC - April 2016, Vol 7, No 3
in
Value in Oncology
Impact of Financial Toxicity on Health-Related Quality of Life
Chase Doyle
VBCC - April 2016, Vol 7, No 3
in
Value in Oncology
Anthem’s Response to Survivorship Medicine: Reimbursement Based on Care Coordination and Patient Outcomes
Chase Doyle
VBCC - March 2016, Vol 7, No 2
in
Survivorship
New Survey: Physicians Are Not Addressing Financial Distress in Patients with Multiple Myeloma
Chase Doyle
VBCC - March 2016, Vol 7, No 2
in
Value in Oncology
Clinical Advances with Targeted Therapies for CLL Also Carry High Economic Burden
Chase Doyle
VBCC - March 2016, Vol 7, No 2
in
Value in Oncology
A New Paradigm for Survivorship Care: Assessing the Patient’s Priorities
Chase Doyle
VBCC - March 2016, Vol 7, No 2
in
Survivorship
Clinical Pathways and the Oncology Medical Home: First Steps to Value-Based Patient Care
Chase Doyle
VBCC - February 2016, Vol 7, No 1
in
Value in Oncology
Value-Based Purchasing: Implications for Hematology
Chase Doyle
VBCC - February 2016, Vol 7, No 1
in
Value in Oncology
Redesigning the Payment Model for Acute Leukemia: Benefits and Challenges of the Episode-of-Care Model
Chase Doyle
VBCC - February 2016, Vol 7, No 1
in
Value in Oncology
Measuring Value in Healthcare to Improve Quality
Chase Doyle
VBCC - February 2016, Vol 7, No 1
in
Value in Oncology
Nilotinib Yields Better Rates of Molecular Response Than Imatinib in Frontline Setting
Chase Doyle
VBCC - February 2016, Vol 7, No 1
in
Leukemia Highlights
Immunotherapy with Blinatumomab Prolongs Survival in Acute Lymphoblastic Leukemia
Chase Doyle
VBCC - February 2016, Vol 7, No 1
in
Leukemia Highlights
Addressing Fertility Issues in Patients with Breast Cancer
Chase Doyle
VBCC - December 2015, Vol 6, No 11
in
Survivorship
Treating Sexual Dysfunction in Breast Cancer Survivors
Chase Doyle
VBCC - December 2015, Vol 6, No 11
in
Survivorship
Communication with Oncologists, Not Cost, Tops Patients’ Value Priorities
Chase Doyle
VBCC - September 2015, Vol 6, No 8
in
Value in Oncology
Immunotherapies Steal the Show at ASCO 2015
Chase Doyle
VBCC - September 2015, Vol 6, No 8
in
Immunotherapy
Rheumatology Fellows Shine in Florida: Research Highlights from NYRIF
Chase Doyle
VBCR - August 2015, Volume 4, No 4
in
Rheumatology Update
Inhaled Levodopa Provides Rapid Motor Improvements in Patients with Parkinson’s Disease
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Parkinson’s Disease
Racial Disparities in Daily Activities After Stroke: Why Are Outcomes Worse in African Americans?
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Stroke
Sodium Valproate Reduces Pain in Pediatric Patients with Migraine
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Headache Management
Patient-Reported Outcomes in Secondary-Progressive Multiple Sclerosis
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Multiple Sclerosis
Best Practices in Multiple Sclerosis
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Multiple Sclerosis
Study Identifies Predictors of Outcomes in Patients with Mild Ischemic Stroke
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Stroke
Antipsychotics Increase Mortality in Parkinson’s Disease
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Parkinson’s Disease
Screening Tool Predicts Risk for Dementia in Patients with Parkinson’s Disease
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Parkinson’s Disease
Increased Use of Sodium Channel Blockers May Reduce Costs in Partial-Onset Seizures
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Health Economics
Parameters Affecting Treatment Decisions for Patients with Multiple Sclerosis
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Health Economics
Sex Differences in Response to Tramadol Therapy
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Chronic Pain
Unemployment Status Linked to Disability in Secondary-Progressive Multiple Sclerosis
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Health Economics
New Biomarkers Identify Chronic Pain Severity
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Chronic Pain
Opioid Abuse Risk in Patients with Chronic Pain
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Chronic Pain
The Search for Value-Based Healthcare Delivery: The Agenda for Oncology
Chase Doyle
VBCC - July 2015, Vol 6, No 6
in
Value in Oncology
Anthem’s Clinical Pathways Demonstrate Value: The Payer Perspective
Chase Doyle
VBCC - July 2015, Vol 6, No 6
in
Value in Oncology
Value Propositions in Oncology: The Physician Perspective
Chase Doyle
VBCC - July 2015, Vol 6, No 6
in
Value in Oncology
Reinventing Disease: A Systematic Approach to Translational Rheumatology
Chase Doyle
VBCR - June 2015, Volume 4, No 3
in
CCR Conference Highlights
Microglial Modulation: The Key to Treating Neuroinflammatory Disease
Chase Doyle
VBCR - June 2015, Volume 4, No 3
in
CCR Conference Highlights
Biosimilars and Dose Reductions Will Reduce the Costs of Biologics
Chase Doyle
VBCR - June 2015, Volume 4, No 3
in
CCR Conference Highlights
Lupologists Seek “Holy Grail” of Biomarkers
Chase Doyle
VBCR - June 2015, Volume 4, No 3
in
CCR Conference Highlights
Psoriatic Arthritis: Treating the Totality of Disease
Chase Doyle
VBCR - June 2015, Volume 4, No 3
in
CCR Conference Highlights
Tendinopathy at the Molecular Level: A Translational Journey
Chase Doyle
VBCR - June 2015, Volume 4, No 3
in
CCR Conference Highlights
Combination Immunotherapy Superior to Monotherapy in Patients with Melanoma
Chase Doyle
VBCC - June 2015, Vol 6, No 5
in
ASCO 2015 Highlights
Should Neurologists Prescribe Opioids for the Management of Chronic Pain?
Chase Doyle
VBCN - May 2015 Volume 2, No 1
in
Side Effect Management
Teriflunomide Demonstrates Significant Efficacy in Patients with Multiple Sclerosis
Chase Doyle
VBCN - May 2015 Volume 2, No 1
in
Multiple Sclerosis
High Doses of Biotin Improve Physical, Neurologic Function in Patients with Progressive Multiple Sclerosis
Chase Doyle
VBCN - May 2015 Volume 2, No 1
in
Multiple Sclerosis
Nonpsychoactive Cannabidiol Helps Children with Severe Epilepsy
Chase Doyle
VBCN - May 2015 Volume 2, No 1
in
Epilepsy Management
Preventing Disease Relapse in Patients with Multiple Sclerosis May Reduce Associated Costs
Chase Doyle
VBCN - May 2015 Volume 2, No 1
in
Health Economics
Inpatient Care Coordination Could Impact Clinical Outcomes, Duration of Hospital Stays
Chase Doyle
VBCN - May 2015 Volume 2, No 1
in
Health Economics
Inpatient Costs for MS-Related Disease Relapse Higher for Males Than for Females
Chase Doyle
VBCN - May 2015 Volume 2, No 1
in
Health Economics
Differences in Disease Burden Examined
Chase Doyle
VBCN - May 2015 Volume 2, No 1
in
Parkinson’s Disease
Is the Science of Stem Cells Ready?
Chase Doyle
VBCN - May 2015 Volume 2, No 1
in
Clinical Trials
Should Whole-Exome Sequencing Be Integrated into Neurologic Care?
Chase Doyle
VBCN - May 2015 Volume 2, No 1
in
Personalized Medicine in Neurology
Sunitinib Associated with Higher Costs Compared with Pazopanib in Patients with Renal-Cell Carcinoma
Chase Doyle
VBCC - April 2015, Vol 6, No 3
in
Economics of Cancer Care
Choice of Hospital for Readmissions Influences Mortality Risk in Men with Urologic Cancer
Chase Doyle
VBCC - April 2015, Vol 6, No 3
in
Economics of Cancer Care
Regorafenib in Metastatic Colorectal Cancer: High Cost with Little Benefit
Chase Doyle
VBCC - March 2015, Vol 6, No 2
in
Economics of Cancer Care
Increasing the Understanding of Rheumatic Diseases
Chase Doyle
VBCR - February 2015, Volume 4, No 1
in
Practice Management
Economic Value of Survival Gains for MDS Could Exceed $100 Billion
Chase Doyle
VBCC - February 2015, ASH 2014 Highlights
in
Health Economics
Brentuximab Cost-Effective After Transplant
Chase Doyle
VBCC - February 2015, ASH 2014 Highlights
in
Lymphoma
Brentuximab Vedotin Cost-Effective After Transplant in Relapsed/Refractory Hodgkin Lymphoma
Chase Doyle
VBCC - February 2015, Vol 6, No 1
in
Economics of Cancer Care
Top 10 Reasons Against Routine Genomic Profiling of Tumors in Patient Care
Chase Doyle
VBCC - February 2015, Vol 6, No 1
in
Personalized Medicine
Value Is Not “Code” for Cost Reduction
Chase Doyle
VBCC - November 2014, Vol 5, No 9
in
Economics of Cancer Care
Symptom Management Drives Value in Oncology
Chase Doyle
VBCC - November 2014, Vol 5, No 9
in
Economics of Cancer Care
Last modified: November 20, 2014
Home
Issues
2018
April 2018, Vol 7, No 1
2017
December 2017, Vol 6, No 5
October 2017, Vol 6, No 4
August 2017, Vol 6, No 3
June 2017, Vol 6, No 2
April 2017, Vol 6, No 1
2016
December 2016, Vol 5, No 6
October 2016, Vol 5, No 5
August 2016, Vol 5, No 4
June 2016, Vol 5, No 3
April 2016, Vol 5, No 2
February 2016, Vol 5, No 1
Issues Archive
Supplements
Categories
Web Exclusives
All Web Exclusives
FDA Approvals, News & Updates
In The News
Online First
Videos
CE
About
About VBCR
About Engage HC
Contact Us
Editorial/Publishing Policies
Editorial Board
Advertising Contacts
Advertising Policy
Author Guidelines
